Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Pietro Majno(Ospedale regionale di Lugano), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Umberto Cillo(University of Padua), Mauro Salizzoni(Azienda Ospedaliero Universitaria San Giovanni Battista), Luciano De Carlis(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Jean Gugenheim(Hôpital l'Archet), Rosalba Miceli(Fondazione IRCCS Istituto Nazionale dei Tumori), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Tiziana Camerini(Fondazione IRCCS Istituto Nazionale dei Tumori), Sherrie Bhoori, Alejandro Forner(Hospital Clínic de Barcelona), Massimo Rossi, Andrew K. Burroughs(University College London), Jordi Bruix(Hospital Clínic de Barcelona), Bart van Hoek(Leiden University Medical Center), Jan Lerut(UCLouvain), Fedja A. Rochling(University of South Florida), Luigi Mariani(Fondazione IRCCS Istituto Nazionale dei Tumori), René Adam(Assistance Publique – Hôpitaux de Paris), Jacques Belghiti(Académie Nationale de Médecine), P. Neuhaus(Charité - Universitätsmedizin Berlin), Marcello Schiavo, Roberto Troisi(Federico II University Hospital), I. Boin, Gian Luca Grazi(Azienda Ospedaliero-Universitaria Careggi), Sasan Roayaie(White Plains Hospital), Giorgio Enrico Gerunda(University of Modena and Reggio Emilia)

The Lancet Oncology

December 5, 2008

Cited by 2,045

|Hepatology|2011|8.1k

|New England Journal of Medicine|1996|7.1k

|Nature Reviews Disease Primers|2021|6.6k

|Hepatology|2005|5.9k

|Journal of Hepatology|2001|4.1k

Related Papers